Technical Analysis for IMDZ - Immune Design Corp.

Grade Last Price % Change Price Change
grade F 1.44 -1.37% -0.02
IMDZ closed down 1.37 percent on Friday, February 15, 2019, on 78 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical IMDZ trend table...

Date Alert Name Type % Chg
Feb 15 Doji - Bullish? Reversal 0.00%
Feb 15 Down 3 Days in a Row Weakness 0.00%
Feb 15 Down 4 Days in a Row Weakness 0.00%
Feb 14 20 DMA Resistance Bearish -1.37%
Feb 14 50 DMA Resistance Bearish -1.37%
Feb 14 Down 3 Days in a Row Weakness -1.37%
Feb 13 Fell Below 20 DMA Bearish -3.36%
Feb 13 Fell Below 50 DMA Bearish -3.36%
Feb 13 MACD Bearish Signal Line Cross Bearish -3.36%
Feb 12 50 DMA Support Bullish -4.64%

Older signals for IMDZ ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Immune Design Corp., a clinical-stage immunotherapy company, focuses on the development of novel immune-based therapies based on its DCVex and GLAAS discovery platforms for cancer and other chronic conditions. Its product candidates in Phase I clinical trials comprise LV305, CMB305, and G305 for the treatment of solid tumor types, such as breast cancer, melanoma, non-small cell lung cancer, ovarian cancer, or sarcoma; and G100 for the treatment of patients with merkel cell carcinoma. The company was formerly known as VaccSys Inc. and changed its name to Immune Design Corp. in June, 2008. The company was founded in 2008 and is headquartered in Seattle, Washington.
Medicine Cancer Clinical Medicine Immunotherapy Cancer Treatments Breast Cancer Non Small Cell Lung Cancer Cancer Immunotherapy Ovarian Cancer Melanoma Targeted Therapy Solid Tumor Merkel Cell Carcinoma Chronic Conditions Sarcoma
Is IMDZ a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.05
52 Week Low 1.1
Average Volume 363,322
200-Day Moving Average 2.8583
50-Day Moving Average 1.501
20-Day Moving Average 1.4965
10-Day Moving Average 1.515
Average True Range 0.0999
ADX 11.96
+DI 17.3897
-DI 20.5756
Chandelier Exit (Long, 3 ATRs ) 1.3503
Chandelier Exit (Short, 3 ATRs ) 1.6297
Upper Bollinger Band 1.6157
Lower Bollinger Band 1.3773
Percent B (%b) 0.26
BandWidth 15.930505
MACD Line 0.0019
MACD Signal Line 0.0102
MACD Histogram -0.0083
Fundamentals Value
Market Cap 36.89 Million
Num Shares 25.6 Million
EPS -2.52
Price-to-Earnings (P/E) Ratio -0.57
Price-to-Sales 6.15
Price-to-Book 1.37
PEG Ratio -0.34
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.52
Resistance 3 (R3) 1.52 1.49 1.50
Resistance 2 (R2) 1.49 1.47 1.49 1.50
Resistance 1 (R1) 1.47 1.46 1.47 1.47 1.49
Pivot Point 1.44 1.44 1.44 1.44 1.44
Support 1 (S1) 1.42 1.42 1.42 1.42 1.39
Support 2 (S2) 1.39 1.41 1.39 1.38
Support 3 (S3) 1.37 1.39 1.38
Support 4 (S4) 1.37